🇺🇸 FDA
Pipeline program

Ivabradine + Usual Care

UW 23-155

Approved small_molecule active

Quick answer

Ivabradine + Usual Care for Atrial Fibrillation (Permanent) is a Approved program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
The University of Hong Kong
Indication
Atrial Fibrillation (Permanent)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials